tiprankstipranks
Illumina (ILMN)
NASDAQ:ILMN

Illumina Stock Forecast & Price Target

3,555 Followers
See the Price Targets and Ratings of:

Analyst Rating Consensus

Hold
14Ratings
4 Buy
8 Hold
2 Sell
Based on 14 analysts giving stock ratings to
Illumina
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ILMN Stock Price Prediction

Average Price Target

$250.00
▲(31.03% Upside)
Based on 14 Wall Street analysts offering 12 month price targets for Illumina in the last 3 months. The average price target is $250.00 with a high forecast of $380.00 and a low forecast of $175.00. The average price target represents a 31.03% change from the last price of $190.79.
Highest Price Target$380.00Average Price Target$250.00Lowest Price Target$175.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Robert W. Baird
$215.00
Hold
12.69%
Upside
Reiterated
Illumina price target lowered to $215 from $306 at BairdIllumina price target lowered to $215 from $306 at Baird
Citigroup
$200.00
Hold
4.83%
Upside
Reiterated
Citigroup Maintains Neutral on Illumina, Lowers Price Target to $200
J.P. Morgan
$300.00
Hold
57.24%
Upside
Reiterated
J.P. Morgan analyst Julia Qin is one analyst who has warned that competition is growing in Illuminas business. In a Friday note, she maintained her Neutral rating on its stock, and reduced her price target from $350 to $300. She cut her forecasts for the companys 2022 adjusted earnings from $4.18 a share to $2.77. For 2023, she cut her number from $5.74, to $3.87.
Morgan Stanley
$240.00
Hold
25.79%
Upside
Reiterated
Morgan Stanley Maintains Equal-Weight on Illumina, Lowers Price Target to $240
Argus Research
$300.00
Buy
57.24%
Upside
Reiterated
Illumina (ILMN) PT Lowered to $300 at ArgusArgus analyst Jasper Hellweg lowered the price target on Illumina (NASDAQ: ILMN) to $300.00 (from $380.00) while maintaining a Buy rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
VTYXVentyx Biosciences
PRVAPrivia Health Group
RXDXPrometheus Biosciences
IMCRImmunocore Holdings
SKINBeauty Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

ILMN Stock Forecast FAQ

What is ILMN’s average 12-month price target, according to analysts?
Based on analyst ratings, Illumina’s 12-month average price target is $250.00.
    What is ILMN’s upside potential, based on the analysts’ average price target?
    Illumina has 31.03% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ILMN a Buy, Sell or Hold?
          Illumina has a conensus rating of Hold which is based on 4 buy ratings, 8 hold ratings and 2 sell ratings.
            What is Illumina’s price target?
            The average price target for Illumina is $250.00. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $380.00 ,the lowest forecast is $175.00. The average price target represents 31.03% Increase from the current price of $190.79.
              What do analysts say about Illumina?
              Illumina’s analyst rating consensus is a ‘Hold. This is based on the ratings of 14 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis